William Blair
http://www.williamblair.comWilliam Blair & Company, L.L.C. is a Chicago-based investment firm offering investment banking, asset management, equity research, institutional and private brokerage, and private capital to individual, institutional, and issuing clients. Since 1935, it has been committed to helping clients achieve their financial objectives.
View Older Stories View More Recent Stories
-
GenMark Prices Public Offering of Common Stock
-
GenMark Prices Public Offering of Common Stock
-
Vapotherm Announces Pricing of Public Offering of Common Stock
-
GenMark Diagnostics (GNMK) to Offer Common Stock
-
Vapotherm (VAPO) Announces Proposed Public Offering of Common Stock
-
Vapotherm Announces Proposed Public Offering of Common Stock
-
EverQuote to Present at Upcoming Virtual Investor Conferences
-
Datadog to Present at Upcoming Investor Conferences
-
EverQuote to Present at Upcoming Virtual Investor Conferences
-
Fortinet Reports First Quarter 2020 Financial Results
-
GenMark Commences Public Offering of Common Stock
-
GenMark Commences Public Offering of Common Stock
-
LivePerson to Participate in Investor Conferences
-
FLIR Systems (FLIR) Thermal Cameras Have Potential for 'Zoom-like Growth' - William Blair
-
UPDATE: William Blair Downgrades American International Group (AIG) to Market Perform
-
UPDATE: William Blair Downgrades Neuronetics (STIM) to Market Perform, Following Earnings
-
William Blair Downgrades Portola Pharmaceuticals (PTLA) to Market Perform
-
Lyra Therapeutics Announces Closing of Initial Public Offering and Exercise in Full of Underwriters’ Option to Purchase Additional Shares
-
Compass Diversified (CODI) Prices 5M Share Common Offering at $17.60/Sh
-
Compass Diversified Holdings Announces Pricing of $88 Million Common Share Offering
-
9 Meters Biopharma, Inc Announces the Closing of $22.5 Million Private Placement Funding
-
Form 497J WILLIAM BLAIR FUNDS
-
Change Healthcare Inc. (CHNG) Announces Sale of its Connected Analytics Business to Kaufman Hall
-
Change Healthcare Announces Sale of its Connected Analytics Business to Kaufman Hall
-
Kaufman Hall Acquires Change Healthcare's Analytics Explorer, Performance Manager and Other Data Capabilities to Create the Industry's Most Robust EPM Software, Data and Analytics Platform
-
Youth INC Launches COVID-19 Response Fund and Commits $1 Million in Grants to Partners
-
Lyra Therapeutics (LYRA) IPO Opens 31% Higher
-
Lyra Therapeutics, Inc. (LYRA) Prices 3.5M Share IPO at $16/Sh
-
Lyra Therapeutics Announces Pricing of Initial Public Offering
-
9 Meters Biopharma, a Rare, Orphan and Unmet Needs GI-Focused Company, is Created with the Transformative Merger Between Innovate Biopharmaceuticals and RDD Pharma
-
Form 497K WILLIAM BLAIR FUNDS
-
Form 497K WILLIAM BLAIR FUNDS
-
Form 497K WILLIAM BLAIR FUNDS
-
Form 497K WILLIAM BLAIR FUNDS
-
Form 497K WILLIAM BLAIR FUNDS
-
Form 497K WILLIAM BLAIR FUNDS
-
Form 497K WILLIAM BLAIR FUNDS
-
Form 497K WILLIAM BLAIR FUNDS
-
Form 497K WILLIAM BLAIR FUNDS
-
Form 497K WILLIAM BLAIR FUNDS
-
Form 497K WILLIAM BLAIR FUNDS
-
Form 497K WILLIAM BLAIR FUNDS
-
Form 497K WILLIAM BLAIR FUNDS
-
Form 497K WILLIAM BLAIR FUNDS
-
Form 497K WILLIAM BLAIR FUNDS
-
Form 497K WILLIAM BLAIR FUNDS
-
Form 497K WILLIAM BLAIR FUNDS
-
Form 497K WILLIAM BLAIR FUNDS
-
Form 497K WILLIAM BLAIR FUNDS
-
Form 497K WILLIAM BLAIR FUNDS

